COVID-19: mRNA vaccines – a promising approach to vaccine development

The urgent need to develop an effective vaccine to provide individuals and populations worldwide with immunity against the COVID-19 disease caused by the novel coronavirus, SARS-CoV-2, has led several biotechnology companies to leverage messenger RNA (mRNA) technology and take a novel approach to vaccine development.   As the COVID-19 pandemic continues to unfold, there are